EX-LAX REGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE- sennosides tablet, chewable

EX-LAX by

Drug Labeling and Warnings

EX-LAX by is a Otc medication manufactured, distributed, or labeled by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, Alps Pharmaceutical Ind. Co., Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Active ingredient

Sennosides 15 mg

Purpose

Stimulant laxative

Uses

• relieves occasional constipation (irregularity)
• generally produces bowel movement in 6 to 12 hours

Warnings

Do not use

laxative products when abdominal pain, nausea or vomiting are present unless directed by a doctor

Ask a doctor before use if you have

noticed a sudden change in bowel habits that persists over a period of 2 weeks

Ask a doctor or pharmacist before use if you are

taking any other drug. Laxatives may affect how other drugs work. Take this product 2 or more hours before or after other drugs.

When using this product

do not use for a period longer than 1 week

Stop use and ask a doctor if

rectal bleeding or failure to have a bowel movement occur after use of a laxative. These may be signs of a serious condition.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

• adults and children 12 years of age and older:

  chew 2 chocolated pieces once or twice daily

• children 6 to under 12 years of age:

  chew 1 chocolated piece once or twice daily

• children under 6 years of age:

  ask a doctor

Other information

• each piece contains: potassium 10 mg
• store at 15-25oC (59-77oF)

Inactive ingredients

cocoa powder, hydrogenated vegetable oils (palm kernel, palm), salt, soy lecithin, sugar, vanilla, whey powder (milk)

Questions or comments?

call 1-855-221-5432

Principal Display Panel

INGREDIENTS AND APPEARANCE

EX-LAX  REGULAR STRENGTH CHOCOLATED STIMULANT LAXATIVE
sennosides tablet, chewable

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 0067-8140
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	15 mg

Inactive Ingredients
Ingredient Name	Strength
COCOA (UNII: D9108TZ9KG)
HYDROGENATED PALM KERNEL OIL (UNII: FM8D1RE2VP)
LECITHIN, SOYBEAN (UNII: 1DI56QDM62)
SUCROSE (UNII: C151H8M554)
VANILLIN (UNII: CHI530446X)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
WHEY (UNII: 8617Z5FMF6)

Product Characteristics
Color	BROWN	Score	no score
Shape	RECTANGLE (Bar)	Size	68mm
Flavor	CHOCOLATE	Imprint Code	ex;lax
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 0067-8140-01	1 in 1 BOX	08/01/2017
1		12 in 1 PACKAGE; Type 0: Not a Combination Product
2	NDC: 0067-8140-02	2 in 1 BOX	08/01/2017
2		12 in 1 PACKAGE; Type 0: Not a Combination Product
3	NDC: 0067-8140-03	4 in 1 BOX	08/01/2017
3		12 in 1 PACKAGE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part334	08/01/2017

Labeler - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263)

Registrant - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263)

Establishment
Name	Address	ID/FEI	Business Operations
Alps Pharmaceutical Ind. Co., Ltd.		717077197	API MANUFACTURE(0067-8140)